Company intelligence / Profile preview

Avieum Life Sciences

Pune, Maharashtra, Indiain.linkedin.com ↗

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Avieum Life Sciences specializes in pre-clinical drug discovery, particularly developing novel inhibitors against Pseudomonas aeruginosa using fragment-based approaches and siderophores for targeted delivery. The company also provides contract research services to pharmaceutical, agrochemical, and fine chemical industries, supporting projects from hit identification through lead optimization and process development. No clinical results or late-stage assets are reported.

Therapeutic areas: Infectious Diseases
Modalities: Small moleculeFragment-based drug discoverySiderophore-drug conjugate
Industry: Biotech

Beyond the preview

Go deeper on Avieum Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avieum Life Sciences.

Explore the full profile